Product Description

🔹 Product Overview
Stivarga 40 mg Tablets are prescription targeted anti-cancer medicines used for the treatment of specific advanced cancers.
Contains Regorafenib 40 mg, a multikinase inhibitor that helps slow the growth and spread of cancer cells.
Commonly prescribed for patients with metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).

🔹 Key Uses
Treatment of metastatic colorectal cancer (mCRC)
Management of gastrointestinal stromal tumors (GIST) after other therapies
Treatment of advanced liver cancer (hepatocellular carcinoma)
Helps slow cancer progression and tumor growth

🔹 Composition
Active ingredient: Regorafenib 40 mg
Belongs to the multikinase inhibitor class
Used in targeted oncology therapy
🔹 How It Works
Blocks multiple protein kinases involved in tumor growth
Reduces blood supply to cancer cells
Helps slow the spread and multiplication of cancer cells

🔹 Key Benefits
Effective targeted cancer therapy tablet
Helps manage advanced and metastatic cancers
Supports slowing of tumor progression
Oral tablet formulation for convenient administration

🔹 Dosage and Administration
Take exactly as prescribed by an oncologist
Usually taken once daily for a specific treatment cycle
Best taken after a low-fat meal
Swallow tablets whole with water

🔹 Possible Side Effects
Fatigue
Hand-foot skin reaction
Diarrhea
High blood pressure
Loss of appetite
Liver function changes

🔹 Precautions
Use under strict medical supervision
Regular liver function and blood pressure monitoring may be required
Inform doctor about heart disease or liver disorders
Avoid pregnancy during treatment
Do not alter dosage without medical advice